PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease

Movement Disorders : Official Journal of the Movement Disorder Society
J O RinneU Ruotsalainen

Abstract

[11C]Raclopride uptake to dopamine D2 receptors was investigated with positron emission tomography (PET) in patients with early Parkinson's disease at the time of the diagnosis and after a half-year interval. During this progressive period of the disease, the patients received no antiparkinsonian medication. The upregulation of striatal D2 receptors, which was seen in all patients already at the time of the diagnosis, persisted. Although the patients initially showed unilateral disease, they had developed bilateral symptoms by the time of the second PET scan, but the disease was still asymmetric. The present results show that the relative increase in [11C]raclopride uptake in the striatum contralateral to the symptoms as compared with the opposite striatum will be preserved even during the progression of the disease, provided that the symptoms show clear-cut asymmetry.

References

Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·U K RinneU Ruotsalainen
Aug 1, 1986·Journal of Neurology, Neurosurgery, and Psychiatry·K L LeendersC D Marsden
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Feb 1, 1984·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·E S GarnettG Firnau

❮ Previous
Next ❯

Citations

Aug 16, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·Dieter SchellerHermann Lübbert
Apr 21, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Maria-João RibeiroAndré Syrota
Jul 25, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Kenji IshibashiKenji Ishii
Jul 7, 2005·Journal of Neurology·Spiridon Papapetropoulos, D C Mash
Mar 1, 2012·Journal of Neural Transmission·P Riederer, J Sian-Hülsmann
Mar 30, 1999·Nuclear Medicine and Biology·R M MorescoB Maziere
Jul 27, 2001·Parkinsonism & Related Disorders·P K PalD B Calne
Oct 29, 2000·Trends in Neurosciences·D J Brooks
Apr 13, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Svetlana I CheferAlexey G Mukhin
Oct 30, 2008·Brain : a Journal of Neurology·Sigurros DavidsdottirAlice Cronin-Golomb
Jan 1, 1996·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·A A LammertsmaR S Frackowiak
Aug 1, 1997·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·S M MoerleinM J Welch
Sep 18, 1998·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·H ItoL Farde
Dec 8, 2009·Nuclear Medicine Communications·Kenji IshibashiKiichi Ishiwata
Feb 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·G V Sawle
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·David J Brooks
Jun 5, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·G K WenningW Poewe
Sep 2, 2015·Vision Research·Xiaolin RenAlice Cronin-Golomb
Mar 15, 2014·Journal of Neurology·Flavia NiccoliniMarios Politis
Sep 8, 2011·Progress in Neurobiology·David J Brooks, Nicola Pavese
Apr 22, 1999·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H TanjiY Itoyama
Apr 22, 2004·Lancet Neurology·Paola Piccini, Alan Whone
Mar 9, 2017·NeuroImage. Clinical·Elizabeth Heinrichs-GrahamTony W Wilson
Oct 13, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·R de La Fuente-FernándezA J Stoessl
Dec 6, 2017·International Review of Psychiatry·Adam J Stark, Daniel O Claassen
Jun 3, 2004·Annals of Neurology·Sid GilmanKris Wernette
Jul 13, 2004·Current Opinion in Neurology·Paola Piccini
Sep 23, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Heather L KatzenWilliam Weiner
Apr 29, 2015·Nuclear Medicine Communications·Ismet Sarikaya
Apr 16, 2018·Cell and Tissue Research·P RiedererR Krüger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.